AnnualReports.com – the leading provider of online annual reports to individual and institutional investors.

Affymax, Inc.


Affymax, Inc., a biopharmaceutical company, engages in the development of peptide-based drug candidates to enhance the treatment of serious and life-threatening conditions.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports